Protective effect of Jiechangning decoction in treating experimental ulcerative colitis in guinea pigs

Xiong Wu-jun; Qiu Qi-yu; Qiu De-kai

doi:10.1007/BF02835750

Your Location：

Home >

Browse articles >

Protective effect of Jiechangning decoction in treating experimental ulcerative colitis in guinea pigs

OriginalPaper | Updated：2021-08-27

- Protective effect of Jiechangning decoction in treating experimental ulcerative colitis in guinea pigs
- Protective effect of Jiechangning decoction in treating experimental ulcerative colitis in guinea pigs
- 中国结合医学杂志（英文版） 2005年11卷第1期页码：49-53
- Affiliations：
  
  1. Department of Gastroenterology, Shanghai East Hospital Affiliated to Tongji University,Shanghai
  2. Department of Traditional Chinese Medicine, Tongji Hospital Affiliated to Huazhong University of Science and Technology,China
  3. Shanghai Institute of Digestive Disease, Renji Hospital Affiliated to the Second Medical University of Shanghai,China
- Author bio：
- Funds：
- DOI：10.1007/BF02835750
  中图分类号：
- 纸质出版日期：2005，
Scan for full text
Wu-jun, X., Qi-yu, Q. & De-kai, Q. Protective effect of Jiechangning decoction in treating experimental ulcerative colitis in guinea pigs., Chin. J. Integr. Med. 11, 49–53 (2005). https://doi.org/10.1007/BF02835750

Xiong Wu-jun, Qiu Qi-yu, Qiu De-kai. Protective effect of Jiechangning decoction in treating experimental ulcerative colitis in guinea pigs[J]. Chinese Journal of Integrative Medicine, 2005,11(1):49-53.
Wu-jun, X., Qi-yu, Q. & De-kai, Q. Protective effect of Jiechangning decoction in treating experimental ulcerative colitis in guinea pigs., Chin. J. Integr. Med. 11, 49–53 (2005). https://doi.org/10.1007/BF02835750 DOI：

Xiong Wu-jun, Qiu Qi-yu, Qiu De-kai. Protective effect of Jiechangning decoction in treating experimental ulcerative colitis in guinea pigs[J]. Chinese Journal of Integrative Medicine, 2005,11(1):49-53. DOI： 10.1007/BF02835750.

摘要

Objective: To study the therapeutic effects and mechanism of Jiechangning (JCN) decoction on carrageenan induced experimental ulcerative colitis (UC).Methods: After sensitizing guinea pigs with carrageenan

we established UC animal models by free drinking water containing 2% acid degraded carrageenan (ADC). JCN decoction was orally administered once a day for 2 weeks after carrageenan treatment. Salicylazosulfapyridine (SASP) and normal saline were given to the other two groups as control. The levels of colon lipid peroxide (LPO)

acid phosphatase (ACP) activity and tumor necrosis factor-α (TNF-α) were measured; colitis activity score (CAS) was carried out for assessment of the degree of tissue inflammation and injury; the colonic pathological changes were examined simultaneously with hematoxylin and eosin (HE) and toluidine blue staining used to evaluate the therapeutic effects of JCN decoction and SASP.Results: Experimental colitis models resembling human UC were successfully induced. The levels of tissue LPO

ACP activity and the content of tissue TNF-α were markedly increased in the model group as compared with the normal control group (P<0.01) and were positively correlated with CAS. JCN decoction could reverse these changes like SASP. HE staining showed that JCN decoction and SASP could reduce CAS and the degree of tissue injury

toluidine blue staining revealed that mucosa and submucosa red metachromasia pellets in JCN group and SASP group were markedly fewer than those in the model group.Conclusion: JCN decoction is effective in treating experimental UC

which provides theoretical basis for its clinical application.

Abstract

which provides theoretical basis for its clinical application.

关键词

Jiechangning decoctionUlcerative ColitisTraditional Chinese Medicine Therapy

Keywords

Jiechangning decoctionUlcerative ColitisTraditional Chinese Medicine Therapy

references

Jiang XL, Cui HF. An analysis of 10218 ulcerative colitis cases in China. World J Gastroenterol 2002;8(1): 158–161.

Das KM, Farag SA. Current medical therapy of inflammatory bowel disease. World J Gastroenterol 2000;6(4): 483–489.

Wang ZK, Xin ZP, Fan SD. TCM treatment on UC. World J Gastroenterol 2000;8(3): 340–341.

Qiu QY, Li GC. Self-formulated Jiechangning in treating 43 patients with UC. Hubei J TCM 1992;6(1): 11.

Kitano A, Matsumoto T, Oshitani NE, et al. Distribution and anti-inflammatory effect of mesalazine on carrageenan-induced colitis in the rabbit. CEPP 1996;23(4): 305–309.

Oestreicher P, Nielsen ST, Rainsford KD. Inflammatory bowel disease induced by combined bacterial immunization and oral carrageenan in guinea pigs. Dig Dis Sci 1991;36(4): 461–470.

Dieleman LA, Ridwan BU, Tennyson GS et al. Dextran sulfate sodium induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994;107(6): 1643–1652.

Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351–358.

Singh B, Powrie F, Mortensen NJ McC. Immune therapy in inflammatory bowel disease and models of colitis. Bri J Surg 2001;88(12): 1558–1569.

Marcus R, Watt J. Seaweeds and ulcerative colitis in laboratory animals. Lancet 1969;30: 489–490.

Xiong WJ, Qiu QY, Luo SX, et al. Effect of JCN on intestinal mucosa protection of experimental UC and its mechanisms. Chin J Integr Traditi West Med 1998;18(Suppl): 153–154.

Xiong WJ, Qiu QY. Therapeutic effect of JCN on experimental UC and its mechanisms. Chin J Anorectal Dis 1999;19(7): 13–14.

Kruidenier L, Verspaget H. W. Oxidative stress as a pathogenic factor in inflammatory bowel disease—radicals or ridiculous? Aliment Pharmacol Ther 2002; 16(12): 1997–2015.

Papadakis KA, Targan SR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med 2000;51: 289–298.

Murch SH, Braeggen CP, Walker Smith JA, et al. Location of tumor necrosis factor-α by immunohistochemistry in chronic inflammatory bowel disease. Gut 1993; 34(12): 1705–1709.

Komatsu M, Kobayashi D, Saito K et al. Tumor necrosis factor-alpha in serum of patients with inflammatory bowel disease as measured by a highly sensitive immuno-PCR. Clin Chem 2001;47(7): 1297–1301.

FULL TEXT LINK

More>

浏览量

403

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Effects of Modified Sanhuang Decoction (加味三黄汤) enema on serum tumor necrosis factor-α and colonic mucosa interleukin-1β, interleukin-6 levels in ulcerative colitis rats

Role of β2-adrenoceptor-β-arrestin2-nuclear factor-κB signal transduction pathway and intervention effects of oxymatrine in ulcerative colitis

Review on efficacy and health services research studies of complementary and alternative medicine in inflammatory bowel disease

Relationship between various Chinese medicine types and T-cell subsets in patients with ulcerative colitis